InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Robins Harlan S, Chief Scientific Officer. Officer active across 1 company, notably Adaptive Biotechnologies Corp. In total, 31 reports have been published. Split: 0 buy · 13 sells. Total volume traded: €20m. Activity tracked since 4 May 2021. The latest transaction was disclosed on 21 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Robins Harlan S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
284,800 shares@ US$6.550.051% mcap7.4% of flowCommon StockSEC:0001780851-26-000017:0
278,698 shares@ US$21.720.17% mcap23.9% of flowCommon StockSEC:0001780851-26-000017:1
213,702 shares@ US$22.120.13% mcap18.6% of flowCommon StockSEC:0001780851-26-000017:2
239,351 shares@ US$21.740.15% mcap41.4% of flowCommon StockSEC:0001780851-26-000015:0
146,889 shares@ US$22.450.097% mcap26.3% of flowCommon StockSEC:0001780851-26-000015:1
100,000 sharesCommon StockSEC:0001780851-26-000013:0
6,160 sharesCommon StockSEC:0001780851-26-000013:1
10,000 shares@ US$14.850.0062% mcap4.0% of flowCommon StockSEC:0001780851-26-000011:0
140,666 shares@ US$13.1714.3% of flowCommon StockSEC:0001780851-26-000007:0
127,813 shares0Common StockSEC:0001780851-26-000005:0
10,000 shares@ US$15.720.0065% mcap4.2% of flowCommon StockSEC:0001780851-26-000003:0
34,668 shares@ US$18.600.027% mcap17.2% of flowCommon StockSEC:0001780851-26-000002:0
10,000 shares@ US$16.440.0068% mcap4.4% of flowCommon StockSEC:0001780851-26-000001:0
27,212 shares@ US$18.610.021% mcap13.8% of flowCommon StockSEC:0001780851-25-000003:0
10,000 shares@ US$14.821.3% of flowCommon StockSEC:0001780851-25-000002:0
68,412 shares@ US$6.3210.8% of flowCommon StockSEC:0001062993-25-008509:0
1,698 shares@ US$6.320.3% of flowCommon StockSEC:0001062993-25-006335:0
355,000 shares0Common StockSEC:0001062993-25-004810:0
354,610 shares0Common StockSEC:0001062993-24-005760:0
354,610 shares0Common StockSEC:0001062993-23-006322:0
247,117 shares0Common StockSEC:0001209191-22-017394:0
3,700 shares@ US$6.550.0010% mcap0.7% of flowCommon StockSEC:0001209191-21-065839:0
3,800 shares@ US$6.550.0010% mcap0.7% of flowCommon StockSEC:0001209191-21-061319:0
3,895 shares@ US$6.320.0010% mcap0.7% of flowCommon StockSEC:0001209191-21-060115:0
3,895 shares@ US$6.320.1% of flowCommon StockSEC:0001209191-21-056261:0
25 of 31 declarations
About Robins Harlan S
ROBINS HARLAN S is Chief Scientific Officer at Adaptive Biotechnologies Corp (XNAS). Across 28 filings, the 28 sampled filings cover the period from 2021-05-06 to 2026-07-07, with EUR 0 in purchases and EUR 10,547,290 in sales, and the most common transaction nature is Levée d'options.
